1. Repository of OAI
Ελληνικά   English  

Browsing by Author Liberopoulos, E. N.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 20 of 117  next >
TitleAuthor(s)Issue date???itemlist.???
Absence of SLC22A12 gene mutations in Greek Caucasian patients with primary renal hypouricaemiaTzovaras, V.; Chatzikyriakidou, A.; Bairaktari, E.; Liberopoulos, E. N.; Georgiou, I.; Elisaf, M. S.24-Nov-2015-
Acute infection with Epstein-Barr virus is associated with atherogenic lipid changesApostolou, F.; Gazi, I. F.; Lagos, K.; Tellis, C. C.; Tselepis, A. D.; Liberopoulos, E. N.; Elisaf, M.24-Nov-2015-
Alcohol intake, serum uric acid concentrations, and risk of goutLiberopoulos, E. N.; Miltiadous, G. A.; Elisaf, M. S.24-Nov-2015-
Aliskiren, a direct renin inhibitor, in clinical practice: a new approach in the treatment of hypertensionMoutzouri, E.; Florentin, M.; Elisaf, M. S.; Mikhailidis, D. P.; Liberopoulos, E. N.24-Nov-2015-
Alterations of paraoxonase and platelet-activating factor acetylhydrolase activities in patients on peritoneal dialysisLiberopoulos, E. N.; Papavasiliou, E.; Miltiadous, G. A.; Cariolou, M.; Siamopoulos, K. C.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Analysis of antihypertensive effects of statinsMilionis, H. J.; Liberopoulos, E. N.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015-
Apolipoprotein E polymorphism and the risk of acute nephropathy after cardiac surgeryLiberopoulos, E. N.; Tsouli, S.; Elisaf, M. S.24-Nov-2015-
Are the pleiotropic effects of drugs used for the prevention of cardiovascular disease clinically relevant?Elisaf, M. S.; Liberopoulos, E. N.24-Nov-2015-
Are the pleiotropic effects of telmisartan clinically relevant?Rizos, C. V.; Elisaf, M. S.; Liberopoulos, E. N.24-Nov-2015-
Assessing the treatment effect in metabolic syndrome without perceptible diabetes (ATTEMPT): a prospective-randomized study in middle aged men and womenAthyros, V. G.; Ganotakis, E.; Kolovou, G. D.; Nicolaou, V.; Achimastos, A.; Bilianou, E.; Alexandrides, T.; Karagiannis, A.; Paletas, K.; Liberopoulos, E. N.; Tziomalos, K.; Petridis, D.; Kakafika, A.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015-
Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT studyAthyros, V. G.; Karagiannis, A.; Ganotakis, E. S.; Paletas, K.; Nicolaou, V.; Bacharoudis, G.; Tziomalos, K.; Alexandrides, T.; Liberopoulos, E. N.; Mikhailidis, D. P.24-Nov-2015-
Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohortAthyros, V. G.; Liberopoulos, E. N.; Mikhailidis, D. P.; Papageorgiou, A. A.; Ganotakis, E. S.; Tziomalos, K.; Kakafika, A. I.; Karagiannis, A.; Lambropoulos, S.; Elisaf, M. S.24-Nov-2015-
Atorvastatin versus micronized fenofibrate in the treatment of patients with mixed hyperlipoproteinemiaMilionis, H. J.; Bairaktari, E. T.; Liberopoulos, E. N.; Elisaf, M. S.24-Nov-2015-
Beneficial effects of omega-3 fatty acids: the current evidenceGazi, I.; Liberopoulos, E. N.; Saougos, V. G.; Elisaf, M. S.24-Nov-2015-
Clinical use of Nebivolol in the treatment of chronic heart failureLiberopoulos, E. N.; Elisaf, M. S.24-Nov-2015-
Colesevelam hydrochloride in clinical practice: a new approach in the treatment of hypercholesterolaemiaFlorentin, M.; Liberopoulos, E. N.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Combined treatment with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: a review of the current evidenceTsouli, S. G.; Liberopoulos, E. N.; Kiortsis, D. N.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Combining rosuvastatin with sartans of different peroxisome proliferator-activated receptor-gamma activating capacity is not associated with different changes in low-density lipoprotein subfractions and plasma lipoprotein-associated phospholipase ARizos, C. V.; Liberopoulos, E. N.; Tellis, C. C.; Florentin, M.; Elisaf, M. S.; Tselepis, A. D.24-Nov-2015-
Combining Rosuvastatin with Sartans of Different Peroxisome Proliferator-Activated Receptor-gamma Activating Capacity Is Not Associated with Different Changes in Low-Density Lipoprotein Subfractions and Plasma Lipoprotein-Associated Phospholipase A(2)Rizos, C. V.; Liberopoulos, E. N.; Tellis, C. C.; Florentin, M.; Elisaf, M. S.; Tselepis, A. D.24-Nov-2015-
Comparison of hemoglobin A1c and fasting glucose criteria to diagnose diabetes among people with metabolic syndrome and fasting glucose above 100 mg/dL (5.5 mmol/L)Liberopoulos, E. N.; Florentin, M.; Kei, A.; Mountzouri, E.; Agouridis, A.; Elisaf, M. S.24-Nov-2015-
Showing results 1 to 20 of 117  next >